Financials
Financial year 2025
PHARMACIE CENTRALE DE MAURAGE from La Louvière, company number BE0878494059, closed financial year 2025 with a result of € 117,241 after tax. For that financial year PHARMACIE CENTRALE DE MAURAGE recorded a gross margin of € 512,644 and equity of € 543,113. Compared with financial year 2024, the result moved from € 127,876 to € 117,241. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 543,113
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 117,241
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 137,813
▼ 69% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 71,429 paid out
61 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
4.4
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 267,680
▲ 2% vs 2024
€ 60,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 71,382
▲ € 61,083 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 103,528
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 140,618
▼ 48% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 402,716 | € 551,942 | € 586,048 | € 512,644 | ▼ 13% |
| Profit after taxes | € 185 | € 382,563 | € 127,876 | € 117,241 | ▼ 8% |
| Equity | € 52,114 | € 375,339 | € 497,300 | € 543,113 | ▲ 9% |
| Total debts | € 194,297 | € 339,906 | € 447,627 | € 325,056 | ▼ 27% |
| Cash | € 645,698 | € 260,619 | € 451,590 | € 137,813 | ▼ 69% |
| Land & buildings | € 30,279 | € 30,771 | € 35,656 | € 143,688 | ▲ € 108,032 |
| Retained profit | € 33,514 | € 356,739 | € 478,700 | € 524,513 | ▲ 10% |
| Dividend | € 0 | € 0 | € 5,915 | € 71,429 | ▲ € 65,514 |
| Balance sheet total | € 1,110,412 | € 715,245 | € 944,927 | € 868,169 | ▼ 8% |
| Employees (FTE) | - | - | 4.2 | 4.4 | ▲ 0.2 |
Key figures of PHARMACIE CENTRALE DE MAURAGE, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE CENTRALE DE MAURAGE?
What happened at PHARMACIE CENTRALE DE MAURAGE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 117,241 (▼ 8% vs 2024). Source: NBB ↗
- New establishment in La Louvière. KBO
- Start of the company according to the CBE. KBO
In short
From € 185 profit in 2021 to € 117,241 profit in 2025.
Paid € 272,279 in corporate taxes since 2021.
Best year ever: 2023, with € 382,563 profit.
On average € 116,500 of value added per employee in 2025.
A new publication or filing at PHARMACIE CENTRALE DE MAURAGE? We notify you, reason included.
Follow PHARMACIE CENTRALE DE MAURAGEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE CENTRALE DE MAURAGE are Freddy DELPATURE and Karine HANSART.
Directors
According to the 2025 annual accounts
Freddy DELPATURE
Director
Karine HANSART
Director
Establishments
Establishment units
Physical locations of this company
Rue Centrale(M) 12
7110 La Louvière
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
OVH, FR
Domain
Domain
pharmacodel.com
Registered
2013-06-27
Registrar
Gandi SAS
Expires
2027-06-27
Website info
Features
Security
Details
- Company number
- 0878.494.059
- VAT number
- BE 0878.494.059
- Registered office
- Rue Centrale(M) 12, 7110 La Louvière
- Names & denominations
- PHARMACIE CENTRALE DE MAURAGE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2006
- Peppol
- Active · Active since 12 Dec 2025
- Contact
- pharmacodel.com [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers